[Moxifloxacin: results of clinical use].
Iakovlev
V P
VP
A. V. Vishnevsky Institute of Surgery, Russian Academy of Medical Sciences, Moscow.
Polushkina
N R
NR
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001372:Aza Compounds; D029481:Bronchitis, Chronic / Q000188:drug therapy; D002986:Clinical Trials as Topic; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D011014:Pneumonia / Q000188:drug therapy; D011804:Quinolines; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin